Valuation: Sinotherapeutics Inc.

Market Cap 3.33B 500M 454M 419M 378M 714M 46.68B 741M 5.05B 2B 25.19B 1.87B 1.83B 79.58B P/E 2024
35.9x
P/E 2025 88.2x
Enterprise Value 2.59B 388M 352M 325M 293M 554M 36.22B 575M 3.92B 1.55B 19.55B 1.45B 1.42B 61.75B EV / Sales 2024
7.4x
EV / Sales 2025 8.08x
Free-Float
25.56%
Yield 2024
0.62%
Yield 2025 0.36%
1 day-1.46%
1 week-6.67%
Current month-5.60%
1 month-15.97%
3 months-30.39%
6 months-19.26%
Current year-23.51%
1 week 7.33
Extreme 7.33000000
8.77
1 month 7.33
Extreme 7.33000000
9.05
Current year 7.02
Extreme 7.02
11.33
1 year 7.02
Extreme 7.02
11.33
3 years 6.3
Extreme 6.3
14
5 years 6.3
Extreme 6.3
28
10 years 6.3
Extreme 6.3
28
Manager TitleAgeSince
Chief Executive Officer 53 06/04/2023
Director of Finance/CFO 57 30/04/2025
Investor Relations Contact 44 31/05/2023
Director TitleAgeSince
Chairman 53 18/08/2020
Director/Board Member 58 01/08/2012
Director/Board Member 44 01/09/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.46%-6.67%-33.09%-37.70% 507M
-1.70%-3.35%+34.87%+132.46% 1,261B
-0.67%-1.48%+38.13%+84.29% 671B
-1.50%-1.95%+23.67%+109.12% 518B
-0.69%+0.37%+31.53%+70.10% 387B
-2.67%-5.05%+44.92%+36.10% 353B
-1.35%-0.95%+28.90%+56.00% 300B
-1.13%-1.80%+0.59%+35.03% 283B
-2.16%-4.17%+30.40%+69.05% 248B
-0.22%+0.19%+33.71%+123.76% 211B
Average -1.38%-1.30%+23.36%+67.82% 423B
Weighted average by Cap. -1.41%-0.55%+31.51%+92.12%

Financials

2024 2025
Net sales 512M 76.72M 69.65M 64.34M 58.04M 110M 7.17B 114M 775M 307M 3.87B 288M 282M 12.22B 447M 66.97M 60.79M 56.16M 50.66M 95.64M 6.26B 99.31M 677M 268M 3.38B 251M 246M 10.67B
Net income 128M 19.15M 17.38M 16.06M 14.49M 27.35M 1.79B 28.4M 194M 76.54M 965M 71.85M 70.34M 3.05B 47.48M 7.12M 6.46M 5.97M 5.39M 10.17M 665M 10.56M 71.95M 28.46M 359M 26.72M 26.15M 1.13B
Net Debt -734M -110M -99.86M -92.24M -83.22M -157M -10.28B -163M -1.11B -440M -5.55B -413M -404M -17.52B -746M -112M -102M -93.87M -84.68M -160M -10.46B -166M -1.13B -447M -5.64B -420M -411M -17.83B
Projected Income Statement - Annual - Sinotherapeutics Inc.
Logo Sinotherapeutics Inc.
Sinotherapeutics Inc is a China-based company mainly engaged in the research and development, product registration, production and sales of generic drugs, as well as contract research organization/contract manufacture organization (CRO/CMO) services. The Company's main products include posaconazole enteric-coated tablets, mesalazine enteric-coated tablets, ursodeoxycholic acid capsules and others. The Company's products cover multiple fields including antifungal, psychiatric, diabetes, cancer, digestive, hypertension, nephrology, and analgesia. The Company's CRO/CMO services are primarily formulation CRO/CMO services, providing pharmaceutical companies and research institutions with specialized formulation development services during drug development and commercial manufacturing services after drug approval through contracts. The Company mainly conducts its business in the domestic and overseas markets.
Employees
319
Date Price Change Volume
18/11/26 CNY 7.420 -1.46% 4,006,799
17/11/26 CNY 7.530 -2.84% 5,020,162
16/11/26 CNY 7.750 -2.52% 5,775,131
13/11/26 CNY 7.950 -3.28% 8,176,937
12/11/26 CNY 8.220 +1.86% 12,083,594
  1. Stock Market
  2. Stocks
  3. 688247 Stock